CORE
đșđŠÂ
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Inhaled alpha 1 -proteinase inhibitor therapy in patients with cystic fibrosis
Authors
Junliang Chen
James F. Chmiel
+6Â more
Scott H. Donaldson
Henry L. Dorkin
Patrick A. Flume
Amit Gaggar
Rhonda Griffin
David Nichols
Publication date
1 January 2016
Publisher
Doi
Cite
View
on
PubMed
Abstract
Inhaled alpha1-proteinase inhibitor (PI) is known to reduce neutrophil elastase burden in some patients with CF. This phase 2a study was designed to test inhaled Alpha-1 HC, a new aerosolized alpha1-PI formulation, in CF patients
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Carolina Digital Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
cdr.lib.unc.edu:1j92gd317
Last time updated on 23/04/2020